Hemin exerts multiple protective mechanisms and attenuates dextran sulfate sodium-induced colitis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 50, Issue 2, 2010, Pages 132-139

  Zhong, Wenwei ^a   Xia, Zhenwei ^a   Hinrichs, David ^b   Rosenbaum, James T ^c   Wegmann, Keith W ^b   Meyrowitz, Jeffery ^d   Zhang, Zili ^d  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Colitis; Inflammatory bowel disease; Interleukin 17; Regulatory T cells

Indexed keywords

DEXTRAN SULFATE; HEME OXYGENASE 1; HEMIN; INTERLEUKIN 17; PROTOPORPHYRIN TIN; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; FLOW CYTOMETRY; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; COLITIS; COLON; DEXTRAN SULFATE; FEMALE; HEME OXYGENASE-1; HEMIN; INFLAMMATION MEDIATORS; INTERLEUKIN-17; INTESTINAL MUCOSA; METALLOPORPHYRINS; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; PROTOPORPHYRINS; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

MURINAE; MUS;

EID: 76349114510     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181c61591     Document Type: Article

References (61)

1. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;7:521-533
2. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347: 417-429
3. Carpenter HA, Talley NJ. The importance of clinicopathological correlation in the diagnosis of inflammatory conditions of the colon: histological patterns with clinical implications. Am J Gastroenterol 2000;95:878-896
4. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314:1461-1463
5. Van Limbergen J, Russell RK, Nimmo ER, et al. The genetics of inflammatory bowel disease. Am J Gastroenterol 2007;102:2820-2831
6. Cho JH, Abraham C. Inflammatory bowel disease genetics: Nod2. Annu Rev Med 2007;58:401-416
7. Nurieva R, Yang XO, Martinez G, et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007;441: 231-234
8. Zhou L, Ivanov II, Spolski R, et al. IL-6 programs Th-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007;8:967-974
9. Fujino S, Andoh A, Bamba S, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003;52:65-70. (Pubitemid 36020767)
10. Nielsen OH, Kirman I, Rüdiger N, et al. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand J Gastroenterol 2003;38:180-185
11. Zhang Z, Zheng M,Bindas J, et al. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis 2006;12:382-388
12. Zhang Z, Hinrichs DJ, Lu H, et al. After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease? Int Immunopharmacol 2007;7:409-416
13. Allez M, Mayer L. Regulatory T cells: peace keepers in the gut. Inflamm Bowel Dis 2004;10:666-676
14. Huibregtse IL, Van Lent AU, Van Deventer SJ. Immunopathogenesis of IBD: insufficient suppressor function in the gut? Gut 2007;56:584-592
15. Tang Q, Bluestone JA. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 2008;9:239-244
16. Yu QT, Saruta M, Avanesyan A, et al. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis. Inflamm Bowel Dis 2007;13:191-199
17. Maul J, Loddenkemper C, Mundt P, et al. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 2005;128:1868-1878.
18. XiaZW, ZhongWW, Meyrowitz JS, et al. The role of heme oxygenase-1 in T cell-mediated immunity: the all encompassing enzyme. Curr Pharm Des 2008;14:454-464
19. Pae HO, Lee YC, Chung HT. Heme oxygenase-1 and carbon monoxide: emerging therapeutic targets in inflammation and allergy. Recent Pat Inflamm Allergy Drug Discov 2008;2:159-165
20. Exner M, Minar E, Wagner O, et al. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 2004;37:1097-1104
21. Ryter SW, Otterbein LE, Morse D, et al. Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem 2002;234-235:249-263
22. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008;8:523-532
23. George JF, Braun A, Brusko TM, et al. Suppression by CD4+CD25+ regulatory T cells is dependent on expression of heme oxygenase-1 in antigen-presenting cells. Am J Pathol 2008;173:154-160
24. Xia ZW, Zhong WW, Xu LQ, et al. Heme oxygenase-1-mediated CD4+CD25high regulatory T cells suppress allergic airway inflammation. J Immunol 2006;177:5936-5945
25. Sardana MK, Kappas A. Dual control mechanism for heme oxygenase: tin(IV)-protoporphyrin potently inhibits enzyme activity while markedly increasing content of enzyme protein in liver. Proc Natl Acad Sci 1987;84:2464-2468
26. Maloy KJ. The interleukin-23/interleukin-17 axis in intestinal inflammation. J Intern Med 2008;263:584-590
27. Ahern PP, Izcue A, Maloy KJ, et al. The interleukin-23 axis in intestinal inflammation. Immunol Rev 2008;226:147-159
28. Korn T, Bettelli E, Oukka M, et al. IL-17 and Th17 cells. Annu Rev Immunol 2009;27:485-517.
29. Bach FH. Heme oxygenase-1 and transplantation tolerance. Hum Immunol 2006;67:430-432
30. Soares MP, Bach FH. Heme oxygenase-1 in organ transplantation. Front Biosci 2007;12:4932-4945
31. Chora AA, Fontoura P, Cunha A, et al. Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J Clin Invest 2007;117:438-447
32. Chatila TA. Role of regulatory T cells in human diseases. J Allergy Clin Immunol 2005;116:949-959
33. Bluestone JA, Tang Q. How do CD4+CD25+ regulatory T cells control autoimmunity? Curr Opin Immunol 2005;17:638-642
34. Nakae S, Nambu A, Sudo K, et al. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003;171: 6173-6177
35. Nakae S, Saijo S, Horai R, et al. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci U S A 2003;100:5986-5990
36. Albanesi C, Cavani A, Girolomoni G. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFNgamma and TNF-alpha. J Immunol 1999;103:1345-1352
37. Pène J, Chevalier S, Preisser L, et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008;180:7423-7430
38. Andoh A, Ogawa A, Bamba S, et al. Interaction between interleukin-17- producing CD4+ T cells and colonic subepithelial myofibroblasts: what are they doing in mucosal inflammation? J Gastroenterol 2007;42 (Suppl 17):29-33.
39. Kolls JK, Lindén A. Interleukin-17 family members and inflammation. Immunity 2004;21:467-476
40. Zhou L, Lopes JE, Chong MM, et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008;453:236-240
41. Lochner M, Peduto L, Cherrier M, et al. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ ROR{gamma}t+ T cells. J Exp Med 2008;205:1381-1393
42. Du J, Huang C, Zhou B, et al. Isoform-specific inhibition of ROR {alpha}-mediated transcriptional activation by human FOXP3. J Immunol 2008;180:4785-4792
43. Yang J, Yang M, Htut TM, et al. Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma t. Eur J Immunol 2008;38:1204-1214
44. Yoshida H, Yoshiyuki M. Regulation of immune responses by interleukin-27. Immunol Rev 2008;226:234-247
45. Mucida D, Park Y, Cheroutre H. From the diet to the nucleus: vitamin A and TGF-beta join efforts at the mucosal interface of the intestine. Semin Immunol 2009;21:14-21.
46. Ivanov II, Zhou L, Littman DR. Transcriptional regulation of Th17 cell differentiation. Semin Immunol 2007;19:409-417
47. Elson CO, Cong Y, McCracken VJ, et al. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 2005;206:260-276
48. Yoshihara K, Yajima T, Kubo C, et al. Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice. Gut 2006;55:334-341
49. Shintani N, Nakajima T, Okamoto T, et al. Involvement of CD4+ T cells in the development of dextran sulfate sodium-induced experimental colitis and suppressive effect of IgG on their action. Gen Pharmacol 1998;31:477-481 (Pubitemid 28398878)
50. He D, Wu L, Kim HK, et al. CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J Immunol 2006;177:6852-6858
51. Michel ML, Keller AC, Paget C, et al. Identification of an IL-17- producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 2007;204:995-1001.
52. O'Brien RL, Roark CL, Born WK. IL-17-producing gammadelta T cells. Eur J Immunol 2009;39:662-666
53. Shibata K, Yamada H, Hara H, et al. Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol 2007;178:4466-4472
54. Shibata K, Yamada H, Nakamura R, et al. Identification of CD25+ gamma delta T cells as fetal thymus-derived naturally occurring IL-17 producers. J Immunol 2008;181:5940-5947
55. Edelblum KL, Yan F, Yamaoka T, et al. Regulation of apoptosis during homeostasis and disease in the intestinal epithelium. Inflamm Bowel Dis 2006;12:413-424
56. Schulzke JD, Ploeger S, Amasheh M, et al. Epithelial tight junctions in intestinal inflammation. Ann N Y Acad Sci 2009;1165:294-300.
57. Torchinsky MB, Garaude J, Martin AP, et al. Innate immune recognition of infected apoptotic cells directs Th17 cell differentiation. Nature 2009;458:78-82.
58. Fransen JH, Hilbrands LB, Ruben J, et al. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17. Arthritis Rheum 2009;60:2304-2313
59. Hegazi RA, Rao KN, Mayle A, et al. Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J Exp Med 2005;202:1703-1713
60. Berberat PO, A-Rahim YI, Yamashita K, et al. Heme oxygenase-1- generated biliverdin ameliorates experimental murine colitis. Inflamm Bowel Dis 2005;11:350-359
61. Wang WP, Guo X, Koo MW, et al. Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats. Am J Physiol Gastrointest Liver Physiol 2001;281:G586-94.